Lyka Labs Ltd
NSE: LYKALABS BSE: 500259
₹62.35
(-3.33%)
Tue, 03 Mar 2026, 11:30 pm
Market Cap2.24B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Other
24.5KCompany History
1976
- The company was incorporated as a private Limited Company
1985
- The company was converted into a Public Limited company
1993
- The Company proposed to offer Equity Shares
1994
- The company negotiated tieup arrangements with internationally reputed manufacturers
1995
- Government of India selected the Company for the award of the Certificate of Merit
- The Company commenced production at its new formulation plant at Tarapur
- The Company set up additional manufacturing facility for ointment at Ankleshwar
- Lyka Exports Limited became a subsidiary of the Company
- The Company allotted Equity Shares to Foreign Institutional Investors and Promoters
1997
- The Company allotted Secured Redeemable Non-Convertible Debentures
- Lyka Labs Limited entered into the marketing of skin cream
- The company launched a rubefacient
1998
- The Companys Administrative Office and Corporate Quality Assurance at Mumbai and Plant at Tarapur was awarded ISO 9002 Certification
1999
- Lyka Labs launched a product-rationalisation exercise
- The company launched dermatological skin ointment Cetraben
2000
- The Company issued equity shares on preferential basis to Financial Institutions FIIs MFs
2003
- Entered into an agreement with BDR Pharmaceuticals International to form a joint venture
- Lyka Labs marketing tie-up with Bio X-Healthcare
- Lyka Labs Ltd decided to dis-invest its holding in Lyka Exports Ltd
2005
- Lyka Labs launches BIOXTRA Toothpaste Gel
- Clearwater Capital Partners Limited joined hands with Lyka Labs Ltd
2006
- Lyka Labs Ltd changed the Registrar and Transfer Agent to Sharex Dynamic India Limited
2008
- Mr DG Shah was appointed as Additional Director
2009
- Shri NI Gandhi was re-appointed as Managing Director
2010
- Mr Manish Jaywant was appointed as CFO
2011
- The Company was conferred Certificate of Appreciation Patent Award
- The Company entered MOU with European based Company for Transfer Known-How Technology
2012
- The company updated its email ID
2014
- Mr Yogesh B Shah was appointed as Chief Finance Officer
2016
- Lyka Healthcare Limited launched two domestic marketing divisions
2017
- Amalgamation of Lyka Healthcare Ltd with Lyka Labs Ltd
2021
- Merger of Lyka Exports Limited with Lyka Labs Limited
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800